Search results

MSIF grants over £500,000 to MS organisations to help them through the pandemic.

With over 500 million people across the world who speak Spanish there is an obvious need for access to MS information in Spanish.

New evidence suggests that fatigue is linked with higher levels of disability, greater levels of depression and anxiety, and poorer cognitive function and sleep in people with MS

‘Tawasol’ (which translates to ‘communicate’) is our newsletter for MS organisations in the Arab region.

Researchers in Canada have investigated the natural history of 500 people with primary progressive MS

Advice for people with MS - updated on 21 March

EBV infection and its relation to MS is an interesting area of ongoing work.

Abdelfatah Ibrahim, MS International Federation (MSIF)’s Head of Communications, Campaigns and Advocacy attends a workshop organised by the Sudanese MS Society for refugees with MS

'EM Força' is about raising funds and awareness through running

Live well with MS as you get older

Seven principles for quality of life based on the insights and experience of people affected by MS

The emotional and cognitive effects of MS are often its greatest challenges

Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time

MS can cause changes that affect a person's usual way of expressing sexuality

Fatigue is one of the most common, troubling symptoms experienced by people with MS. For some people, it is the symptom that affects them most.

Smoking increases your risk of developing MS – both as a smoker and through passive smoking. Learn more about the impact of smoking on MS.

Seeking an experienced individual with skills in all aspects of HR, facilities management, a ‘can-do’ attitude and flexibility in team work.

Global MS employment report shows many people with MS are leaving employment earlier than necessary

MS is usually thought of as an adult condition, but children and teenagers can also develop it

The final issue of MS in focus in the current format is now available to download in Arabic, English, French and Spanish

Swedish study favours rituximab over fingolimod for those at risk of progressive multifocal leukoencephalopathy

Stichting MS celebrates 40 years of MS research with a campaign on resilience. The Dutch MS organisation has partnered with local researchers and the UK MS Society to put their work in the spotlight.

Leaders of the International Progressive MS Alliance have published a paper proposing a global research strategy to prioritise and coordinate the efforts needed to find more and better treatments, and improve quality of life of people living with progressive MS.

Explore our new booklet for people affected by MS: ‘Living well with MS as you grow older’

The Stop MS appeal aims to raise £100m to find treatments for everyone with MS in the UK. Find out how the campaign made national headlines.

Together we're stronger than MS

Summary of findings from the 2010 employment survey

The global MSIF movement's seven principles to improve quality of life with MS

Collaborative Network Planning Awards Granted as part of €22 million global effort to End Progressive MS

Research suggests a rise in the number of people estimated to be living with MS in the UK.

Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS

Digital fundraising learnings from MS organisations in Latin America

Subject experts highlight the advances, unanswered questions and new challenges in understanding, diagnosis and management

MSIF's McDonald Fellowships fund 2-year research placements for early career researchers from low- and middle-income countries.

Adapting the MS Society of India’s ‘Guide for MS Caregivers’ for a global audience.

Ms Kyoko Nakata from Japan wins the 2017 James D. Wolfensohn Award

Professor Alan Thompson highlights some of 2016’s research discoveries in MS

Studies provide insight into the links between MS prevalence, severity, latitude and healthcare spending

MS researcher Arman Eshaghi answers questions from around the world

Translating and adapting Fatigue: an invisible symptom of MS.

MSIF is pleased to announce the winner of this year’s Young Investigators Award: Dr Floor C. Loonstra

We are looking for a strong communicator to support the World MS Day team at our friendly London office.

A powerful series of animated graphics based on the experiences of teenagers with MS in Italy.

Several healthcare companies answer MSIF's call to help MS organisations through pandemic

The award is given for the best presentation of a translational project by a young researcher

MSIF’s Atlas of MS with new data on the number of people living with MS across the world, and the challenges they face.

Sean Hegarty from the UK is in his mid-forties and lives with relapsing progressive MS

Examples of accessible resorts and services shared by our members

MS can affect expressions of intimacy in several different ways

Contribute to the development and implementation of MSIF’s regional strategies and programmes

We are seeking an experienced consultant to contribute to the evaluation and analysis of MSIF’s regional strategies and programmes in Latin America.

MSIF's team of 20 seeks enthusiastic individual with an aptitude for developing & implementing supportive policies, practices & workplaces

MSIF are hiring a Finance Officer

MSIF's income comes from a variety of supporters

We are the only global network of MS organisations

How do genes affect the risk of developing MS?

A one-page summary of MSIF's recently published information statement on EBV and MS.

Latest news from 17 organisations in the Arab region

MS is associated with high costs for MS patients, their families, and society as a whole

Support MSIF on this once in a lifetime experience, as you trek along one of the most spectacular wonders of the world.

Support MSIF on this trek to Machu Picchu, one of the most iconic sights in South America.

Addressing barriers to accessing treatment at a global, regional and national level

The MS International Federation is committed to protecting the privacy of the users of its website

MS Queensland’s annual “Brissie to the Bay” bike ride a huge fundraising success for people living with MS

Tools for the #bringinguscloser campaign for World MS Day 2018 are now available to download.

World MS Day will take place on 30 May. The 2018 campaign is called Bringing Us Closer and the theme is Research.

A great opportunity to work on an MS International Federation (MSIF) advocacy project in India

Advocating for the addition of MS treatments to the WHO Essential Medicines List

Support MSIF by Running the most challenging marathon of your life, along one of mankind’s greatest monuments.

Shining a spotlight on MS in the region

The Atlas of MS is the most extensive worldwide study of the disease

In August Sarah Dobson, MSIF’s Senior Communications and Campaigns Officer, met with local MS organisations in Taiwan and South Korea.

'I still remember every tiny detail about my job. I still know how a woman’s garment should be tailored, but I cannot thread a needle.'

'To even get my diagnosis I had to borrow money from others.'

The theme for World MS Day 2014 was access

Support MSIF by taking part is this classic cycle.

Support MSIF by trekking up one of the world’s ‘Seven Summits’, on the Kilimanjaro Trek. This is an event you dont want to miss

Support MSIF on this once in a lifetime experience, as you trek in the glow of the most spectacular nature show on earth.

Temporary part-time role to support our Arab region capacity building work

Nothing captures the work and values of MSIF more that this event and we wanted to share their story of a global marathon movement

Ride the toughest Tour de France Mountains just a few weeks before the professionals

Putting the experience of people affected by MS at the heart of research, care and health policy

Rehabilitation is the part of managing of MS that focuses on function

The theme for this year's World Brain Day is Stop multiple sclerosis

Neurologists carry out a number of tests to find out whether someone has MS.

Up to two-thirds of people with MS report pain as a symptom in worldwide studies

MS can cause problems with movement, balance and coordination

MSIF is pleased to announce the winner of this year’s Young Investigators Award: Dr Silke Häusser-Kinzel.

MS affects people all over the world. MS registries are one of the many advances in MS research that are bringing us closer as a global MS community and closer to ending MS.

Information for women with MS about the symptoms and long-term effects of menopause and how these can be managed

Bladder and bowel problems can range from mild incontinence or constipation to more severe problems

MS can affect many aspects of daily family life

The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’

Answers to the most frequently asked questions about our application to add MS treatments to the WHO EML.

Provide information on the number of people with MS and barriers to accessing healthcare to key decision-makers in your country.

Time for a victory lap, The May 50K fundraisers have raised £1.25 million this year!

Esclerosis Múltiple Argentina and the MS Society of Canada sign up to the challenge

Latest news from MS organisations in the Arab region

Latest news from MS organisations in the Arab region

The latest news from MS organisations in the Arab region

Research shows links between lifestyle factors and depression outcomes for people with MS.

Asociación de Lucha contra la Esclerosis Múltiple (ALCEM) has become MS International Federation’s third supporting organisation

Helen Onuorah receives the 2020 Young Investigator Award on her project "Racial inequalities in MS research participation"

Six months into the COVID-19 Response Initiative

World MS Day 2012 was based on three riddles about MS

Support MSIF and take part in the Ho Chi Min To Ankor Wat Cycle, and discover one of the wonders of the world Angkor Wat. This is part of our world wonder series.

The deadline for applications for McDonald fellowships and Du Pré Grants is 30 June 2018

Support MSIF and take part in the Everest Base Camp Climb, the starter of what is described as the ultimate challenge on this earth, Mt Everest!

Support MSIF and take part in the Rajasthan Cycle. This cycles takes you break taking Indian landscape to one of the New Seven Wonders of the World, the Taj Mahal

Support MSIF and take part in the Trek to Ancient Petra. Trek through the famous desert and gorge leading to one of the New Seven Wonders of the World, Petra

MSIF's income comes from a variety of supporters

Survey results show a high hypothetical interest in physician-assisted death in people with MS

World MS Day 2017 takes place on 31st May and the theme is #LifewithMS

People with MS can have many happy and productive years

There is no cure for MS, but people can find their own way to live with the disease and to try to live in a healthy way

We are looking for a consultant(s) to support our country-focused programme work in Morocco

A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s advocacy work to increase funding for MSSNs

Biomarkers is a term that often comes up when we talk about MS treatment and clinical trials - but what are they and why are they important?

To stop MS, we need treatments that repair damage to the protective myelin coating around nerves.

Find out more about your chance to enter the first ever MS Brain Health Awards

There are two World Days coming up which will be of interest to the global MS community.

The Russian MS society president has raised awareness by appearing on two Russian TV programmes

Podcast recommendations from the MSIF movement

Advocacy examples from the global MS movement to inspire you today.

It is important for people with MS to have the best available information on stem cell therapy to make decisions related to this complex issue.

Three people needed to help shape the work of the Alliance

MSIF is seeking experienced Spanish-speaking consultants, preferably based in Uruguay, to provide training and mentoring in the areas of project planning and fundraising.

Are you a fundraiser? We have a great opportunity to play a crucial role in the fundraising and communication for a global campaign.

Unpaid caregivers play a vital role in the lives of people with MS

This article delves into the land of genetics, explaining the method called ‘Mendelian randomisation’, which scientists use to learn about links between genes and disease.

Advocating for the addition of MS treatments to the WHO Essential Medicines List

22 July – join the conversation this World Brain Day

Discover how MS organisations collaborate to translate vital MS information.

The MS International Federation encourages everyone affected by MS to sign the declaration

Dorothy Shoes uses her photography to demonstrate the impact MS has on her life

MS International Federation’s capacity-building manager, Abdelfatah Ibrahim, visits Morocco

Three MSIF members sign up for the challenge

A study funded by the International Progressive MS Alliance shows a blood test may have potential in helping to predict future MS activity and response to therapy.

Global MS experts update recommendations for the differential diagnosis of MS

The second World MS Day took place in 2010 with the theme 'Employment'

Our board generally meets twice a year

Complementary and alternative therapies for MS may be potentially beneficial, ineffective or harmful

MS International Federation is an international organisation with members in 44 countries

The first round-the-world yacht trip crewed by people with MS is now in the Pacific

You can access the site in Arabic, English, French, Portuguese and Spanish

Nearly 2,000 people took part in the 2014 MS in focus online survey on ageing with MS

The post-2015 development agenda will be launched in New York in September 2015

We are seeking a Research Insight Analyst for a project this November

We are looking for a Spanish speaking facilitator for the third regional meeting of MS associations in the Latin America region

Whether you are fundraising in honour of someone, for fun or for a personal challenge. This fundraising pack helps you stay on target in the fight against MS.

The 'My Invisible MS' toolkit is now available online

Thank you for helping us on our mission for a world without MS! Right Click to Download!

Start collecting COVID-19 and MS data

Your update from MS organisations in the Arab Region

Your update from MS organisations in the Arab Region

On 6 October, 650 people affected by MS gathered in Barcelona for the ‘Living with MS Day’ event

Challenges and next steps considered

Conquer the highest peaks of the Tour de France to raise funds for MS!

Latest news from 16 organisations in the Arab region

World MS Day 2019 will take place on 30 May. The theme is Visibility and the campaign is called My Invisible MS.

The Israel MS Society celebrates 40 years with a free music video for MS societies around the world to use for raising awareness, fundraising, and empowering people affected by MS

The next ‘Understanding MS’ online course starts in March 2023

Moving away from traditional clinical categories of MS may lead to better, and more personalised treatments for MS.

Results from the first clinical trial using neural stem cells to treat people with MS

New publication highlights regional disparities in the management of MS

The International Progressive MS Alliance works to speed up the development of treatment for progressive MS

Each year, seasoned riders from around the world take on over 400km of the toughest climbs from the Tour De France just weeks before the official race. It's the ride that every cyclist dreams of, but only the toughest can complete.

Working to improve access to MS treatments in low-resource settings.

New research explores challenges around MS management in the region.

Latest news from 14 organisations in the Arab region

Latest news from MS organisations in the Arab region

The Alliance has been joined by four MS International Federation member organisations

Autologous Haematopoietic Stem Cell Transplantation (AHSCT) is being investigated as a treatment for MS

Many people with MS experience delays in diagnosis and are often misdiagnosed. Consider what can be done to improve awareness and improve early diagnosis.

A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS

Latest news from 17 organisations in the Arab region

Research and clinical trials are taking place around the world, trying to find and improve treatments for MS

Support MSIF and take part in The Marathon des Sables, the toughest footrace on earth (Discovery Channel).

Prof. Sørensen, one of the world’s prominent clinical neurologists in multiple sclerosis, recognised for lifetime achievement in improving understanding and treatment of MS.

Laura Musambayi, founder of the MS Association of Kenya, visited the National MS Society in the US to share best practice and develop new approaches to improve MS Kenya’s operations.

A new study has revealed an interaction between two types of immune cells that may contribute to MS.

Grant Saunders beats his The May 50K target, walking 2.4 million steps during lockdown!

Researchers are addressing the gaps in information about the impact of COVID-19 on people with MS in Latin America.

One marathon, once a month until I raise one million dollars!

Third annual meeting (Encuentro) brings together MS organisations from 16 Latin American countries to share learnings and work towards shared solutions to common challenges.

Catch up with the 2022 annual meeting on the PROMS initiative

The Progressive MS Alliance has awarded its first round of 22 research grants to investigators in nine countries

Brave cyclists take on the Tour de France route

The deadline for applications for McDonald fellowships and Du Pré Grants is 30 June 2017

Researchers and health professionals gather for the latest updates and research findings on treatment, care and management of MS

MSIF has formed a mutually beneficial relationship with the corporate sector over many years

Resistance exercise increases the thickness of the brain cortex in some people with MS

Two recent scientific publications have reported on the long term safety and efficacy of Alemtuzumab (Lemtrada) for the treatment of relapsing-remitting MS

Latest figures show prevalence of MS continues to increase in many countries

The research questions identified as priority topics by over 1000 people affected by MS and healthcare professionals

Two new publications emphasise global research collaboration across the MSIF movement.

People around the world fundraise for Kiss Goodbye to MS campaign

Support MSIF in one of the most beautiful cities in Europe at the TCS Amsterdam Marathon

Support MSIF in Jamaica’s premier International Marathon Event, the Reggae Marathon

More than 900 health professionals and representatives from 38 countries gathered in Dubai for MENACTRIMS 2017, which featured a special joint session with MSIF.

Canadian research shows people with MS are more likely than the general population to visit a doctor or hospital in the years leading up to an MS diagnosis.

A new study has shown a link between high blood pressure and heart disease and an increased loss of brain volume in people with MS.

Protecting and advocating for the rights of people with MS is at the heart of our work

Current and past fellows of MSIF and ECTRIMS come together in Barcelona to share experiences

The latest and most thorough studies do not show an association between CCSVI and MS

Stories from MS Australia show the power of the Creative Arts to improve health and wellbeing

Inspiring speeches and research news at the Society’s event in Tokyo

People affected by MS across Poland showcased their artistic creations at the Polish MS Society’s fifth annual Abilympics

Several thousand people came to see performances from popular artists and learn about MS in a series of debates

MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants

New Support Line will provide information and support, as well as jobs for people living with MS

First lady Brigitte Macron offered support to the French League Against Multiple Sclerosis in a landmark meeting at the Elysée Palace.

Stichting MS Research welcomed the global MSIF movement in Amsterdam last month for the spring 2018 Global Networking meetings.

Cykelnerven is a yearly event that raises money for life-changing research into Multiple Sclerosis (MS). Changing routes each year, the event takes cyclists on one of the toughest mountain stages of the subsequent Tour de France

Trial results show that Pilates, an exercise for strengthening core muscles, improves walking distance and mobility in MS.

Exploring the link between genetics and the risk of developing MS.

This paper was first published in Nature January 2021

The Atlas of MS is inspiring countries to tackle MS-data gaps. Find out how MS organisations are harnessing the power of data to advocate for change.

We are governed by our Council of Members

The UK MS Society’s campaign calls for the right treatment at the right time

Brazilian MS Association ABEM is taking part in a campaign to highlight the importance of mental health and mental health professionals

MSIF has endorsed recommendations in a new report to emphasise the importance of early diagnosis and treatment in MS

MS Ireland produced a list of questions for candidates to find out where they stand on key issues relating to MS

Thought Sort is designed to improve wellbeing. The impact of the tool will be measured in a research study.

Stichting MS Research will fund two of MSIF’s Du Pré grants

Strengthening our collaboration with ECTRIMS

Researchers uncover a molecule that promotes regeneration of myelin

Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more

New research shows that sun exposure over a lifetime can change the course of MS.

The UK MS Society’s campaign calls on the government to change criteria of Personal Independence Payments (PIP), a vital disability benefit for people with MS.

A look back at what the global MS movement has achieved during the pandemic.

Register for the 'Using the Atlas of MS for change' event by completing the form below.

Traffic light guidelines : acknowledging pharmaceutical funding

What does research tell us about how DMTs affect the body’s immune response to COVID-19 vaccines?

Does EBV cause MS?

In June 18 MSIF cyclists  took on Europe’s most challenging charity cycling event - Cykelnerven.

Importance of training and education for healthcare professionals is highlighted in new publication

Issue 17: 11 organisations from the Arab region share their news

Latest news from 17 organisations in the Arab region

The latest news from the Multiple Sclerosis (MS) associations in the Arab region.

Step into the lab and meet Dr María José Ulloa Navas, a talented MS researcher from Ecuador. María José spoke with MSIF about her career so far, what drives her, and how she helps people affected by MS in her home country of Ecuador.

MSIF's work relating to off-label DMTs for MS

'We always have hope that things will be better in the future and that one day we will manage to find a final cure for MS. Until that time, we have to follow the latest research.'

'MS has had a massive impact on my life. I used to love dancing, but can do that no longer!'

Zuzanna is in her 20s and works as a neuropsychologist, an anthropologist of culture and a journalist. She lives in Warsaw.

The Mumbai Chapter organised a programme of talks in Surat, Gujarat

Stacey Black ran a half-marathon in memory of her grandmother

Teresa was diagnosed with MS 24 years ago. To celebrate World MS Day 2015 she walked a mile for each year she’s had MS.

Ahmed Darwish from Egypt has won the 2015 James D. Wolfensohn Award

Along with five friends, Vanessa spent the last few days of 2015 climbing Kilimanjaro for the MS cause

Fly for MS is raising awareness of MS in an unusual way

How common is obesity in people with MS and is it related to disability?

Research in the USA finds no link between salt intake and time to relapse in children with MS

People with MS test out new accessible facilities

Sharing tips for #LifewithMS and events for World MS Day

Greater support in Israel for people affected by MS

Support MSIF as Paris hosts one of the largest and most popular events of its kind in Europe.

Support MSIF and take part in the Chicago Marathon, one of the best races in the world.

Support MSIF and take part in the 40th Melbourne Marathon

Brazilian MS Association hosts dance event in Sao Paulo to mark National Multiple Sclerosis Day

The Danish MS Society is reaching out to people in Denmark through videos and social media to raise funds for, and awareness of, MS.

MSIF’s Capacity Building Manager visits Arfa MS Society to launch MSIF’s new country-focused programme in the Kingdom of Saudi Arabia.

Anti-histamine drug clemastine may boost myelin repair in MS

Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health

Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that drain blood from the brain and spinal cord over a prolonged period.

Expert panel publishes revised criteria for MS diagnosis

Support MSIF and take part in the New York Marathon, every runner's "must-do" event

Screening of almost 250 medications has identified clomipramine as a possible treatment for progressive MS.

Australian researchers have found that the electrical activity of nerve cells in the brain plays an important role in the growth of myelin. This laboratory discovery may lead to new interventions to promote myelin repair in MS.

A new study has identified three changes within people’s genes that are linked to different disease courses in MS.

Against MS is the DIY fundraising initiative for the MS International Federation because as the leaders of the global movement we stand as one world Against MS.

The MS Society of India celebrated India MS Day with a national bike rally. Learn more about how this year’s activities helped raise awareness across the country.

MS has traditionally been thought of as a condition that mainly affects the white matter of the brain. Recently this notion has been challenged and now research has uncovered a potentially important disease process in the grey matter.

New research on the relationship between processed and non-processed red meat consumption and the risk of developing MS

The International Pediatric MS Study Group (IPMSSG) have updated recommendations for standards in pediatric clinical trials.

Highlights from World MS Day 2019

MS organisations campaign for better access to treatments in Morocco.

Find out how Conor tackled one of Europe’s most challenging charity cycling events.

MS Australia’s Mark Campbell tells us how the animation was developed and why it’s been such a success.

The Polish MS Society make MS visible in their annual Symphony of Hearts campaign.

The MS Society of Canada’s Burgers to Beat MS campaign raises over $2 million for MS. Find out what they learned along the way.

MS organisations throughout Latin America meet in Colombia to strengthen regional partnerships.

Many people with MS in the United States face barriers in accessing treatments.

The 3rd edition of the Atlas has been released

A new campaign by the Multiple Sclerosis Society of India highlights the gaps in disability assessment guidelines.

Advances in treatment and research.

Being Black and living with MS brings unique challenges. The Black MS Experience Summit created a safe space for the Black MS community in the United States to connect, learn and share stories.

Esclerosis Múltiple Uruguay (EMUR) share their recent work and reflect on the positives at this time of great challenge.

Everyone with MS has a different set of symptoms

Problems with vision are often one of the first symptoms noticed by people with MS

The Convention was adopted by the UN General Assembly in 2006

App uses scientifically designed exercises to improve memory and concentration

Sheela Chitnis, founding member of MS Society of India (MSSI), featured in India’s #Beboldforchange campaign for International Women’s Day

MS Ireland launches two major new publications on early treatment and diagnosis of MS

“Planbaby bei MS” offers support and advice on starting a family to young adults with MS

An exciting opportunity to lead the search for improved understanding and treatments for MS and better access to treatments and healthcare

A flavour of how global MS organisations marked World MS Day 2017

A new study recently published uses ‘real-world’ data to investigate the effects of disease modifying therapies on secondary progressive MS

“My MS, My Needs” survey results help MS Ireland to improve services and advance advocacy work for people with MS.

New evidence of potential role of gut bacteria in MS

Singer Keiko joined young supporters of the Japan MS Society for a festive, awareness-raising event at an elementary school.

MSIF’s ‘Seven principles to improve quality of life with MS’, already available in English, Spanish, Arabic, and Italian, have now been translated into Greek.

Two recent scientific publications add further evidence that a simple eye test may offer a fast and easy way to monitor the progression of MS.

Queen Maxima of the Netherlands and two Olympic speed skaters will join delegates.

The National MS Society launched a new awareness-raising campaign during the US MS Awareness Week 2018, engaging hundreds of thousands of people through its PR activities.

Interim results from one of the first randomised controlled trials comparing autologous haematopoietic stem cell transplant (AHSCT) to other MS therapies have been presented at a Lisbon conference.

The New Zealand Multiple Sclerosis Research Trust invited Professor Helmut Butzkueven, Managing Director of MSBase, to launch the pioneering project in New Zealand.

A phase II clinical trial has shown ibudilast, a repurposed asthma medication, can slow down the rate of brain tissue loss in progressive MS by almost half compared to a placebo treatment.

FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS

Efforts to improve access to MS treatments continue

Deadline for MSIF's Grants and Fellowhips is 30 June 2023

The clinical management part of the Atlas of MS is now available

Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.

MSIF highlights priority actions for MS in the draft global plan

Find out more about the global PROMS meeting

Catch up on the latest webcast on fatigue treatment and research from the International Progressive MS Alliance

Find out more about the Global PROMS Initiative - Patient Reported Outcomes for MS

New survey launched by the International Progressive MS Alliance

Looking for a cycling challenge? Become a tour legend, whilst raising vital funds for MS

The first adaptive clinical trial for Australians living with MS

The Greek Multiple Sclerosis Society’s latest MS event, a guided adventure across Greece

The global community comes together to set priorities for research in women’s health in MS

Researchers have been trialling low current electric brain stimulation as a way to help manage MS related fatigue.

US study shows people who eat fish may be less likely to develop MS.

New research suggests the rate of brain atrophy, or brain shrinkage, may be an important indicator of disease progression in MS.

New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown a link between more effective disease-modifying therapies and an increased level of employment, work attendance and productivity at work.

Driving a truck around the world for MS

Save the date – World Brain Day is on 22 July 2021

Esclerosis Múltiple España is now an associate member of the MS International Federation

New publication from MSIF on ethical use of off-label DMTs receives global endorsement

Research priorities identified to help better understand the MS prodrome

Your guide to successful advocacy. Tools and resources for healthcare professionals, MS organisations and people affected by MS to support their advocacy efforts to improve access to MS healthcare.

'I keep worrying: What if I was unable to get my treatment for a month or so? What will be the consequences?'

'I felt down, empty and lonely when I couldn’t go to the school.'

‘She went to sleep and didn’t wake up for two months’

‘They said ‘if a car is broken, it is useless to repair a tyre when the major problem is the engine’

‘I actually want to be in a more corporate kind of role in which you would be married to your job a bit more. That excites me.’

‘I don't count how many times I fall. I count how many times I stand up.’

'I was left in a situation of being newly diagnosed, scared and with the prospect that I didn't have health coverage.'

Recent advances and promising researches

2024

MS comes in several forms, including clinically isolated syndrome, relapsing-remitting MS, secondary progressive MS and primary progressive MS.

MSIF Du Pré Grants enable multiple sclerosis researchers and clinicians to undertake short placements in established MS research centres and clinics

The Atlas of MS relies on data supplied by MS organisations from around the world

Epidemiological studies have helped to identify factors that may be related to the risk of developing MS

MS can have a big impact on a person's ability to participate in society, remain in employment and have relationships

Monday 2 December was the International Day for Persons with Disabilities

Ann was presented with the K. Venkatanarayana TANKER Foundation Awareness Award in Chennai on 25 January 2013

IPMSSG is more than 150 academic physicians and researchers treating and/or studying MS in children

The register aims to address the recognised lack of relevant MS data at European level

Researchers find that Alfacalcidol is a safe and effective treatment for fatigue

Fampridine must be used with caution in people with a history of MS-related trigeminal neuralgia

French study supports the idea of avoiding delays after pregnancy before starting natalizumab therapy

Study supports a link between the development of grey matter disease and a progressive MS phenotype

‘Make your voice heard’ addressed the challenges faced by MS organisations in Central and Eastern Europe

The main aim was to share knowledge about emotions and stress and their effect on health

New evidence that exercise could reduce patients’ blood interferon level and fatigue

MS Australia launches a new blogging platform for people affected by MS

French MS organisation ARSEP celebrates 26th annual conference

New film project from the German MS Society (DMSG) featuring people with MS to air on German television

MSIF and the Dutch MS Research Foundation launch Global MS Research Booster Award for researchers studying the cause of MS

Keiko, a popular Japanese singer who lives with MS, performed songs to Japanese school pupils who took part in World MS Day 2017.

More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.

What’s behind the media reports on concussion and MS?

Chemistry of brain inflammation linked to mood changes in MS

The Polish MS Society’s annual awareness-raising campaign, “Symphony of Hearts”, has entered its tenth year

Multiple Sclerosis Argentina (EMA) has launched a brand new website and YouTube channel in order to increase its reach to people affected by MS.

The MS Society of India (MSSI) is proud to congratulate Dr Rebecca Verghese, a long-standing volunteer with the society who lives with MS, in winning an award at the “Mrs India Earth” pageant.

Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring people with MS

Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between the two organisations

Current and past fellows of MSIF and ECTRIMS come together in Paris to share experiences

Helmut Butzkueven, who led the development of MSBase with support from MS Research Australia, has received the Data Innovation Award.

Czech MS organisation Union Roska marked its 25th anniversary with the Roskiáda Sports Games, a new sports event for people with MS

New study shows eating a diet high in whole grains, fruit, vegetables and legumes may lead to less disability and depression, and less severe MS symptoms.

The Czech MS organisation Union Roska will invite people affected by MS for a cruise along the river Vltava this World MS Day.

A new study identifies some key differences between the immune system of men and women, which may explain why MS affects the sexes differently.

A new immunotherapy that re-educates the immune system has shown promising results in two early-stage clinical trials.

New research indicates that miRNA, a genetic switch in the blood of people with MS, could help to explain how and why cells that suppress the immune system do not function correctly in MS.

The ‘Peer to Peer’ support programme is designed to support people with MS shortly after diagnosis.

Volunteers from the UK MS Society’s English Council worked with the Rotarian Action Group for MS Awareness (RAGSMA) to attend the event and share information about MS.

New research shows psychiatric disorders are associated with the worsening of MS disability outcomes.

Fingolimod has been approved by the US Food and Drug Administration (FDA) as a treatment for children and young people aged 10 years and older with relapsing MS

A new study has found a link found between brain imaging markers and long-term employment status.

How the biological processes cause progression in different types of MS.

MS Ireland took World MS Day as an opportunity to launch a pioneering research report, designed to help Ireland become a world leader in MS research.

The Russian MS Society embraced nature this World MS Day with a riverside seminar on MS treatment and an activity programme including fishing and horse-riding.

As MS Queensland marks its 60th anniversary, MS Australia celebrates decades of achievements by all four of its state member organisations (MS Queensland, MS Limited, MS Society of South Australia and Northern Territory and MSWA, which services the state of Western Australia).

MSIF staff paid a special visit to India this month to launch an exciting new collaboration with the MS Society of India.

Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.

A study from MSIF McDonald fellow Dr Eshaghi has shown that brain tissue loss, or atrophy, occurs in ’stages’ and follows a predictable order.

Results from a trial of natalizumab in secondary progressive MS suggest anti-inflammatory treatments could slow disability accumulation, even after significant function has been lost.

The Scientific Committee of the French MS Research Support Foundation (ARSEP) has selected recipients for its annual research grants and fellowships.

Genetic screening of people with primary progressive MS has shown that four rare genetic changes, which are known to cause other neurological diseases, may play a role in primary progressive MS.

The Portuguese MS Society (SPEM) is calling on people nationwide to raise awareness of MS through dance as part of its new advocacy campaign, ‘Portugal dances vs MS’.

The ‘Innovation of the Year’ fundraising award was presented in recognition of the Swiss MS Society’s 2017 World MS Day event, ‘We send a signal’.

Up to 80 members of the association will meet in October to learn about a new national healthcare plan and its implications for people living with chronic conditions like MS.

A new study looking at socioeconomic and education levels in Iran has found no relationship to the risk of developing MS.

The UK MS Society will bring together people affected by MS at an interactive event in November as part of a series of ‘Living with MS’ events.

FDA approves the drug Siponimod, to treat people with active secondary progressive MS

EMA conducts safety review of alemtuzumab (Lemtrada)

We explore why people with MS around the world practise yoga and Pilates.

She is the first woman to win the lifetime achievement award for outstanding research into the understanding and treatment of MS

Progressive MS Awards

Sharing data to find answers quicker during COVID-19

The COVID-19 and MS global data sharing initiative is working to provide crucial information on the impact of the coronavirus on people with MS.